title: Relation of the ischaemic substrate to left ventricular remodelling by cardiac magnetic resonance at 1.5 T in rabbits.
abstract: OBJECTIVE
  Contrast-enhanced cardiac magnetic resonance (CMR) for infarct sizing has been validated in large animals, but studies and follow-up are restricted. We sought to (1) validate CMR for assessment of myocardial area at risk (MAR) and infarct size (IS) in a rabbit model of reperfused myocardial infarction (MI); (2) analyse the relation between ischaemic substrates and subsequent left ventricular (LV) remodelling.
  
  
  METHODS
  Experimental reperfused acute MI was induced in 16 rabbits. Ten animals underwent cross-registered cine and contrast-enhanced CMR and histopathology at day 3 for assessment of MAR and IS (group 1). The remaining six rabbits underwent serial CMR for the study of LV remodelling (group 2).
  
  
  RESULTS
  In group 1, mean IS was 12.7 +/- 6.4% and 12.7 +/- 6.9% of total LV myocardial mass on CMR (late-enhancement technique) and histopathology (P = 0.52; r = 0.93). No significant difference occurred between CMR and histopathology for the calculation of MAR and IS/MAR ratio (P = 0.18 and P = 0.17), whereas correlations were strong (r = 0.92 and r = 0.95). In group 2, mean LV end-diastolic, end-systolic volumes and LV mass were significantly increased at 3 weeks compared with measurements at day 3 (P < 0.01). Significant correlations between initial IS and the increase in LV end-diastolic volume (r = 0.66) and the increase in LV mass (r = 0.48) were observed, as well as correlations between initial MAR and the increase in LV end-diastolic volume (r = 0.70) and the increase in LV mass (r = 0.37).
  
  
  CONCLUSIONS
  Comprehensive CMR provides accurate assessment of IS and MAR in reperfused rabbit MI. Infarct size is closely related to LV remodelling. Through the infarct size/MAR ratio, this approach has great potential for assessing interventions aimed at cardioprotection.
authors: INSERM U841, IMRB, Faculté de médecine, Université Paris 12 et Ecole Nationale Vétérinaire d'Alfort, Maisons-Alfort, France.
authors: Nicolas
authors: N
authors: Mansencal
authors: Renaud
authors: R
authors: Tissier
authors: Jean-François
authors: JF
authors: Deux
authors: Bijan
authors: B
authors: Ghaleh
authors: Nicolas
authors: N
authors: Couvreur
authors: Mario
authors: M
authors: Rienzo
authors: Pascal
authors: P
authors: Guéret
authors: Alain
authors: A
authors: Rahmouni
authors: Alain
authors: A
authors: Berdeaux
authors: Jérôme
authors: J
authors: Garot
mesh_terms: D000818:Animals; D016009:Chi-Square Distribution; D003287:Contrast Media / Q000008:administration & dosage; D004195:Disease Models, Animal; D006571:Heterocyclic Compounds / Q000008:administration & dosage; D016014:Linear Models; D008279:Magnetic Resonance Imaging / Q000379:methods*; D019028:Magnetic Resonance Imaging, Cine / Q000379:methods*; D008297:Male; D009203:Myocardial Infarction / Q000473:pathology*; D015425:Myocardial Reperfusion; D009942:Organometallic Compounds / Q000008:administration & dosage; D011817:Rabbits; D020257:Ventricular Remodeling
chemical_list: D003287:Contrast Media; D006571:Heterocyclic Compounds; D009942:Organometallic Compounds; C050823:gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate